![]() |
|||||||
|
Fusion Protein:ANO1-CDC42BPG |
Fusion Gene and Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ANO1-CDC42BPG | FusionPDB ID: 4847 | FusionGDB2.0 ID: 4847 | Hgene | Tgene | Gene symbol | ANO1 | CDC42BPG | Gene ID | 55107 | 55561 |
Gene name | anoctamin 1 | CDC42 binding protein kinase gamma | |
Synonyms | DOG1|ORAOV2|TAOS2|TMEM16A | DMPK2|HSMDPKIN|KAPPA-200|MRCKG|MRCKgamma | |
Cytomap | 11q13.3 | 11q13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | anoctamin-1Ca2+-activated Cl- channelanoctamin 1, calcium activated chloride channelcalcium activated chloride channeldiscovered on gastrointestinal stromal tumors protein 1oral cancer overexpressed 2transmembrane protein 16A (eight membrane-spannin | serine/threonine-protein kinase MRCK gammaCDC42 binding protein kinase gamma (DMPK-like)DMPK-like gammaMRCK gammamyotonic dystrophy kinase-related CDC42-binding kinase gammamyotonic dystrophy protein kinase like proteinmyotonic dystrophy protein kin | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9NW15 Main function of 5'-partner protein: FUNCTION: Does not exhibit calcium-activated chloride channel (CaCC) activity. Can inhibit the activity of ANO1. {ECO:0000269|PubMed:20056604, ECO:0000269|PubMed:22946059}. | Q6DT37 Main function of 5'-partner protein: FUNCTION: May act as a downstream effector of CDC42 in cytoskeletal reorganization. Contributes to the actomyosin contractility required for cell invasion, through the regulation of MYPT1 and thus MLC2 phosphorylation (By similarity). {ECO:0000250|UniProtKB:Q5VT25, ECO:0000269|PubMed:15194684}. | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000316296, ENST00000355303, ENST00000398543, ENST00000530676, ENST00000538023, ENST00000525494, ENST00000531349, | ENST00000491280, ENST00000342711, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 20 X 18 X 9=3240 | 5 X 5 X 5=125 |
# samples | 20 | 5 | |
** MAII score | log2(20/3240*10)=-4.01792190799726 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/125*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Fusion gene context | PubMed: ANO1 [Title/Abstract] AND CDC42BPG [Title/Abstract] AND fusion [Title/Abstract] | ||
Fusion neoantigen context | PubMed: ANO1 [Title/Abstract] AND CDC42BPG [Title/Abstract] AND neoantigen [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ANO1(69951894)-CDC42BPG(64606374), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ANO1-CDC42BPG seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ANO1-CDC42BPG seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ANO1-CDC42BPG seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ANO1-CDC42BPG seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ANO1 | GO:0006812 | cation transport | 22946059 |
Tgene | CDC42BPG | GO:0006468 | protein phosphorylation | 15194684 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:69951894/chr11:64606374) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Amino Acid Sequences |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000355303 | ANO1 | chr11 | 69951894 | - | ENST00000342711 | CDC42BPG | chr11 | 64606374 | - | 5918 | 1052 | 221 | 4831 | 1536 |
ENST00000398543 | ANO1 | chr11 | 69951894 | - | ENST00000342711 | CDC42BPG | chr11 | 64606374 | - | 5662 | 796 | 49 | 4575 | 1508 |
ENST00000538023 | ANO1 | chr11 | 69951894 | - | ENST00000342711 | CDC42BPG | chr11 | 64606374 | - | 5662 | 796 | 49 | 4575 | 1508 |
ENST00000316296 | ANO1 | chr11 | 69951894 | - | ENST00000342711 | CDC42BPG | chr11 | 64606374 | - | 5634 | 768 | 105 | 4547 | 1480 |
ENST00000530676 | ANO1 | chr11 | 69951894 | - | ENST00000342711 | CDC42BPG | chr11 | 64606374 | - | 5754 | 888 | 249 | 4667 | 1472 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000355303 | ENST00000342711 | ANO1 | chr11 | 69951894 | - | CDC42BPG | chr11 | 64606374 | - | 0.004933232 | 0.99506676 |
ENST00000398543 | ENST00000342711 | ANO1 | chr11 | 69951894 | - | CDC42BPG | chr11 | 64606374 | - | 0.003783811 | 0.99621624 |
ENST00000538023 | ENST00000342711 | ANO1 | chr11 | 69951894 | - | CDC42BPG | chr11 | 64606374 | - | 0.003783811 | 0.99621624 |
ENST00000316296 | ENST00000342711 | ANO1 | chr11 | 69951894 | - | CDC42BPG | chr11 | 64606374 | - | 0.004074206 | 0.9959258 |
ENST00000530676 | ENST00000342711 | ANO1 | chr11 | 69951894 | - | CDC42BPG | chr11 | 64606374 | - | 0.00577666 | 0.9942233 |
![]() |
Get the fusion protein sequences from here. |
Fusion protein sequence information is available in the fasta format. >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP |
Top |
Fusion Protein Breakpoint Sequences for ANO1-CDC42BPG |
![]() |
Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Length(fusion protein) | BP in fusion protein | Peptide |
ANO1 | chr11 | 69951894 | CDC42BPG | chr11 | 64606374 | 1052 | 277 | KDSFFDSKTRSTIDHLQFPPDVPDVP |
ANO1 | chr11 | 69951894 | CDC42BPG | chr11 | 64606374 | 768 | 221 | KDSFFDSKTRSTIDHLQFPPDVPDVP |
ANO1 | chr11 | 69951894 | CDC42BPG | chr11 | 64606374 | 796 | 249 | KDSFFDSKTRSTIDHLQFPPDVPDVP |
ANO1 | chr11 | 69951894 | CDC42BPG | chr11 | 64606374 | 888 | 213 | KDSFFDSKTRSTIDHLQFPPDVPDVP |
Top |
Potential FusionNeoAntigen Information of ANO1-CDC42BPG in HLA I |
![]() |
ANO1-CDC42BPG_69951894_64606374.msa |
![]() * We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5) |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA I | FusionNeoAntigen peptide | Binding score | Immunogenic score | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:17 | STIDHLQF | 0.9982 | 0.8475 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:16 | STIDHLQF | 0.9971 | 0.574 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:01 | RSTIDHLQF | 0.9977 | 0.9918 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:01 | RSTIDHLQF | 0.9949 | 0.9753 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:02 | RSTIDHLQF | 0.9946 | 0.9688 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-A30:08 | KTRSTIDHL | 0.9931 | 0.5807 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:17 | RSTIDHLQF | 0.9911 | 0.969 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:16 | RSTIDHLQF | 0.9906 | 0.9485 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:17 | KTRSTIDHL | 0.9819 | 0.8796 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:16 | KTRSTIDHL | 0.9777 | 0.67 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:03 | RSTIDHLQF | 0.9741 | 0.9927 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:03 | KTRSTIDHL | 0.9424 | 0.9727 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-A32:13 | RSTIDHLQF | 0.8184 | 0.9267 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:02 | TRSTIDHLQF | 1 | 0.6634 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:05 | TRSTIDHLQF | 1 | 0.9239 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:04 | TRSTIDHLQF | 0.9999 | 0.8022 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:07 | TRSTIDHLQF | 0.9997 | 0.6249 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:01 | KTRSTIDHLQF | 0.9999 | 0.9769 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:02 | KTRSTIDHLQF | 0.9997 | 0.8468 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:17 | KTRSTIDHLQF | 0.9996 | 0.8986 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:03 | KTRSTIDHLQF | 0.9994 | 0.9848 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B15:16 | KTRSTIDHLQF | 0.9994 | 0.7555 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:01 | KTRSTIDHLQF | 0.9992 | 0.918 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-A30:08 | KTRSTIDHLQF | 0.9902 | 0.5937 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:04 | STIDHLQF | 0.9997 | 0.8034 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C03:14 | STIDHLQF | 0.9964 | 0.9432 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:06 | KTRSTIDHL | 0.9905 | 0.8747 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:04 | RSTIDHLQF | 0.9732 | 0.9329 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C03:14 | RSTIDHLQF | 0.8149 | 0.987 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C07:95 | TRSTIDHLQF | 0.9997 | 0.7442 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C07:19 | TRSTIDHLQF | 0.9993 | 0.6882 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:03 | TRSTIDHLQF | 0.9991 | 0.9366 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C07:46 | TRSTIDHLQF | 0.9986 | 0.8436 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:09 | STIDHLQF | 0.9997 | 0.8034 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C03:02 | STIDHLQF | 0.9997 | 0.9382 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C16:01 | STIDHLQF | 0.9971 | 0.965 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C16:02 | STIDHLQF | 0.9958 | 0.9863 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C02:02 | STIDHLQF | 0.9619 | 0.8723 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C02:10 | STIDHLQF | 0.9619 | 0.8723 | 10 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:10 | RSTIDHLQF | 0.9977 | 0.9918 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:04 | RSTIDHLQF | 0.9954 | 0.7785 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:06 | RSTIDHLQF | 0.9933 | 0.9114 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-A30:01 | KTRSTIDHL | 0.993 | 0.7918 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:02 | KTRSTIDHL | 0.9926 | 0.8307 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:05 | KTRSTIDHL | 0.9905 | 0.8456 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:06 | KTRSTIDHL | 0.9864 | 0.7224 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:02 | RSTIDHLQF | 0.9779 | 0.9621 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C15:09 | RSTIDHLQF | 0.9732 | 0.9329 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-A32:01 | RSTIDHLQF | 0.9449 | 0.9132 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:02 | KTRSTIDHL | 0.9222 | 0.7885 | 7 | 16 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C16:01 | RSTIDHLQF | 0.717 | 0.9845 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C16:02 | RSTIDHLQF | 0.5804 | 0.9944 | 9 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:08 | TRSTIDHLQF | 1 | 0.822 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:10 | TRSTIDHLQF | 0.9999 | 0.9158 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:06 | TRSTIDHLQF | 0.9999 | 0.8204 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C07:01 | TRSTIDHLQF | 0.9998 | 0.6518 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B27:09 | TRSTIDHLQF | 0.9998 | 0.8861 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-C07:22 | TRSTIDHLQF | 0.9993 | 0.6345 | 8 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:04 | KTRSTIDHLQF | 0.9999 | 0.6704 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:10 | KTRSTIDHLQF | 0.9999 | 0.9769 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B58:06 | KTRSTIDHLQF | 0.9998 | 0.7169 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-B57:02 | KTRSTIDHLQF | 0.9994 | 0.8877 | 7 | 18 |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 | HLA-A32:01 | KTRSTIDHLQF | 0.997 | 0.8926 | 7 | 18 |
Top |
Potential FusionNeoAntigen Information of ANO1-CDC42BPG in HLA II |
![]() |
![]() * We used NetMHCIIpan v4.1 (%rank<0.5). |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA II | FusionNeoAntigen peptide | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
Top |
Fusion breakpoint peptide structures of ANO1-CDC42BPG |
![]() * The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA. |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
8714 | SKTRSTIDHLQFPP | ANO1 | CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 768 |
Top |
Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ANO1-CDC42BPG |
![]() * We used Glide to predict the interaction between HLAs and neoantigens. |
HLA allele | PDB ID | File name | BPseq | Docking score | Glide score |
HLA-B14:02 | 3BVN | 8714 | SKTRSTIDHLQFPP | -7.15543 | -7.26883 |
HLA-B14:02 | 3BVN | 8714 | SKTRSTIDHLQFPP | -4.77435 | -5.80965 |
HLA-B52:01 | 3W39 | 8714 | SKTRSTIDHLQFPP | -6.80875 | -6.92215 |
HLA-B52:01 | 3W39 | 8714 | SKTRSTIDHLQFPP | -4.20386 | -5.23916 |
HLA-A11:01 | 4UQ2 | 8714 | SKTRSTIDHLQFPP | -7.5194 | -8.5547 |
HLA-A11:01 | 4UQ2 | 8714 | SKTRSTIDHLQFPP | -6.9601 | -7.0735 |
HLA-A24:02 | 5HGA | 8714 | SKTRSTIDHLQFPP | -7.52403 | -7.63743 |
HLA-A24:02 | 5HGA | 8714 | SKTRSTIDHLQFPP | -5.82433 | -6.85963 |
HLA-B27:05 | 6PYJ | 8714 | SKTRSTIDHLQFPP | -3.28285 | -4.31815 |
HLA-B44:05 | 3DX8 | 8714 | SKTRSTIDHLQFPP | -5.91172 | -6.94702 |
HLA-B44:05 | 3DX8 | 8714 | SKTRSTIDHLQFPP | -4.24346 | -4.35686 |
Top |
Vaccine Design for the FusionNeoAntigens of ANO1-CDC42BPG |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide sequence | FusionNeoAntigen RNA sequence |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 10 | 18 | STIDHLQF | AGCACGATTGACCACCTGCAGTTC |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 7 | 16 | KTRSTIDHL | AAAACCCGGAGCACGATTGACCACCTG |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 7 | 18 | KTRSTIDHLQF | AAAACCCGGAGCACGATTGACCACCTGCAGTTC |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 8 | 18 | TRSTIDHLQF | ACCCGGAGCACGATTGACCACCTGCAGTTC |
ANO1-CDC42BPG | chr11 | 69951894 | chr11 | 64606374 | 9 | 18 | RSTIDHLQF | CGGAGCACGATTGACCACCTGCAGTTC |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide | FusionNEoAntigen RNA sequence |
Top |
Information of the samples that have these potential fusion neoantigens of ANO1-CDC42BPG |
![]() |
Cancer type | Fusion gene | Hchr | Hbp | Henst | Tchr | Tbp | Tenst | Sample |
TGCT | ANO1-CDC42BPG | chr11 | 69951894 | ENST00000316296 | chr11 | 64606374 | ENST00000342711 | TCGA-2G-AAGP-01A |
Top |
Potential target of CAR-T therapy development for ANO1-CDC42BPG |
![]() |
![]() * Minus value of BPloci means that the break point is located before the CDS. |
- In-frame and retained 'Transmembrane'. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
![]() * We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image. |
Hgene | Hchr | Hbp | Henst | Tgene | Tchr | Tbp | Tenst | DeepLoc result |
Top |
Related Drugs to ANO1-CDC42BPG |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ANO1-CDC42BPG |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |